In the context of prostate cancer screening, particularly for patients with PSA values within the diagnostic gray area, TAP detection exhibits superior diagnostic accuracy, and the combined assessment of TAP and fPSA/tPSA is more efficacious. The gene discussed is KLK3; the disease is prostate carcinoma.